What is Acquired Resistance and How Does it Occur?

Submitted by gracevideo on Mon, 10/06/2014 - 06:00

Gregory J. Riely, MD, PhD, GRACE Faculty

Acquired Resistance Forum Video #1: Dr. Gregory J. Riely of Memorial Sloan Kettering Cancer Center opened the Acquired Resistance in Lung Cancer Patient Forum with a basic introduction of how ALK, ROS1 and EGFR lung cancers become resistant to treatment. 

 

Related Content: 
Tagrisso for acquired resistance to Tarceva
EGFR Mutations and Acquired Resistance After Responding
Heterogeneity in Population of NSCLC Patients with Acquired Resistance to EGFR Inhibitors: T790M is Key Predictor
Webinar by Dr. Lecia Sequist on Acquired Resistance to Oral EGFR Inhibitors in Advanced NSCLC
New Hope for EGFR Mutant NSCLC with Acquired Resistance to Tarceva (including T790M!)
HSP 90 Inhibitors: Another Rational Choice for Patients with Acquired Resistance to EGFR Inhibitors
Challenging Cases in Lung Cancer: Acquired Resistance to an EGFR Inhibitor in a Patient with Advanced NSCLC and EGFR Mutation
Early Data on Acquired Resistance to Targeted Therapies: Start Local Therapy, Continue the Targeted Therapy?
Should We Continue the EGFR Inhibitor When We Start Chemo for Acquired Resistance?

 

Join the Conversation

Please feel free to offer comments and raise questions in our
discussion forums.

 Join The conversation